Eupraxia Pharmaceuticals Inc. (EPRX)
NASDAQ: EPRX · IEX Real-Time Price · USD
2.940
-0.010 (-0.34%)
May 17, 2024, 3:59 PM EDT - Market closed
Eupraxia Pharmaceuticals Statistics
Total Valuation
EPRX has a market cap or net worth of $104.73 million. The enterprise value is $78.38 million.
Market Cap | 104.73M |
Enterprise Value | 78.38M |
Important Dates
Earnings Date | n/a |
Ex-Dividend Date | n/a |
Share Statistics
EPRX has 35.62 million shares outstanding. The number of shares has increased by 49.40% in one year.
Shares Outstanding | 35.62M |
Shares Change (YoY) | +49.40% |
Shares Change (QoQ) | +5.51% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | n/a |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 5.36 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.95, with a Debt / Equity ratio of 0.49.
Current Ratio | 1.95 |
Quick Ratio | 1.95 |
Debt / Equity | 0.49 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | n/a |
Return on Capital (ROIC) | n/a |
Revenue Per Employee | n/a |
Profits Per Employee | n/a |
Employee Count | 29 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -43.76% in the last 52 weeks.
Beta (1Y) | n/a |
52-Week Price Change | -43.76% |
50-Day Moving Average | 3.02 |
200-Day Moving Average | 4.29 |
Relative Strength Index (RSI) | 49.40 |
Average Volume (30 Days) | 27,093 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | n/a |
Pretax Income | n/a |
Net Income | n/a |
EBITDA | n/a |
EBIT | n/a |
Earnings Per Share (EPS) | n/a |
Balance Sheet
The company has $35.91 million in cash and $9.56 million in debt, giving a net cash position of $26.35 million or $0.74 per share.
Cash & Cash Equivalents | 35.91M |
Total Debt | 9.56M |
Net Cash | 26.35M |
Net Cash Per Share | $0.74 |
Equity / Book Value | 19.54M |
Book Value Per Share | 0.55 |
Working Capital | 17.69M |
Cash Flow
Operating Cash Flow | n/a |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
EPRX does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -49.40% |
Shareholder Yield | -49.40% |
Earnings Yield | n/a |
FCF Yield | n/a |
Analyst Forecast
Price Target | n/a |
Price Target Difference | n/a |
Analyst Consensus | n/a |
Analyst Count | n/a |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | -25.06% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |